| Date Filed | Type | Description |
| 12/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 12/02/2020 |
4
| Scots-Knight Denise (Director) has filed a Form 4 on Elanco Animal Health Inc|
Txns:
| Granted 5,885 shares
@ $0 |
|
| 12/02/2019 |
4
| Scots-Knight Denise (Director) has filed a Form 4 on Elanco Animal Health Inc|
Txns:
| Granted 5,233 shares
@ $0 |
|
| 04/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/20/2019 |
3
| Scots-Knight Denise (Director) has filed a Form 3 on Elanco Animal Health Inc |
| 06/25/2018 |
4
| Pollard-Knight Denise (Director) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Granted 15,000 options to buy
@ $2.55, valued at
$38.3k
|
|
| 06/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/02/2017 |
4
| Pollard-Knight Denise (Director) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Granted 15,000 options to buy
@ $3.3, valued at
$49.5k
|
|
| 01/25/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/07/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/07/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 06/24/2016 |
4
| Pollard-Knight Denise (Director) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Granted 15,000 options to buy
@ $12.61, valued at
$189.2k
|
|
| 06/23/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/02/2015 |
4
| Pollard-Knight Denise (Director) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Sold 3,799 shares
@ $21.6635, valued at
$82.3k
|
|
| 12/30/2014 |
4
| Pollard-Knight Denise (Director) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Sold 2,195 shares
@ $21.6476, valued at
$47.5k
Sold 9,902 shares
@ $21.6166, valued at
$214k
Sold 5,510 shares
@ $21.649, valued at
$119.3k
|
|
| 12/23/2014 |
4
| Pollard-Knight Denise (Director) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Sold 20,654 shares
@ $21.7057, valued at
$448.3k
|
|
| 12/10/2014 |
4
| Pollard-Knight Denise (Director) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Sold 1,727 shares
@ $21.6761, valued at
$37.4k
Sold 23,273 shares
@ $21.7836, valued at
$507k
Sold 7,940 shares
@ $21.7744, valued at
$172.9k
|
|
| 12/05/2014 |
4
| Pollard-Knight Denise (Director) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Sold 24,245 shares
@ $21.5824, valued at
$523.3k
Sold 755 shares
@ $22.1, valued at
$16.7k
|
|
| 08/05/2014 |
4
| Pollard-Knight Denise (Director) has filed a Form 4 on IDENIX PHARMACEUTICALS INC|
Txns:
| Disposed/sold 20,000 options to buy
@ $8.85, valued at
$177k
Disposed/sold 20,000 options to buy
@ $7.33, valued at
$146.6k
Disposed/sold 20,000 options to buy
@ $6.71, valued at
$134.2k
Disposed/sold 20,000 options to buy
@ $3.49, valued at
$69.8k
Disposed/sold 20,000 options to buy
@ $4.09, valued at
$81.8k
Disposed/sold 20,000 options to buy
@ $4.57, valued at
$91.4k
Disposed/sold 20,000 options to buy
@ $9.03, valued at
$180.6k
Disposed/sold 20,000 options to buy
@ $4.94, valued at
$98.8k
Disposed/sold 20,000 options to buy
@ $6.88, valued at
$137.6k
|
|
| 07/02/2014 |
4
| Pollard-Knight Denise (Director) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Sold 11,485 shares
@ $23.5889, valued at
$270.9k
|
|
| 06/27/2014 |
4
| Pollard-Knight Denise (Director) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Sold 3,252 shares
@ $23.562, valued at
$76.6k
|
|
| 06/25/2014 |
4
| Pollard-Knight Denise (Director) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Sold 52,797 shares
@ $24.1951, valued at
$1.3M
Sold 11,764 shares
@ $23.5736, valued at
$277.3k
|
|
| 06/20/2014 |
4
| Pollard-Knight Denise (Director) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Granted 15,000 options to buy
@ $25.95, valued at
$389.3k
|
|
| 06/06/2014 |
4
| Pollard-Knight Denise (Director) has filed a Form 4 on IDENIX PHARMACEUTICALS INC|
Txns:
| Granted 20,000 options to buy
@ $6.88, valued at
$137.6k
|
|
| 07/23/2013 |
4
| Pollard-Knight Denise (Director) has filed a Form 4 on OncoMed Pharmaceuticals Inc|
Txns:
| Converted 2,063,983 shares
@ $0
Bought 58,824 shares
@ $17, valued at
$1M
Converted 2,063,983 options to buy
@ $0 |
|
| 07/17/2013 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 06/10/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/11/2012 |
4
| Pollard-Knight Denise (Director) has filed a Form 4 on IDENIX PHARMACEUTICALS INC|
Txns:
| Granted 20,000 options to buy
@ $9.03, valued at
$180.6k
|
|
| 06/03/2011 |
4
| Pollard-Knight Denise (Director) has filed a Form 4 on IDENIX PHARMACEUTICALS INC|
Txns:
| Granted 20,000 options to buy
@ $4.57, valued at
$91.4k
|
|
| 06/04/2010 |
4
| Pollard-Knight Denise (Director) has filed a Form 4 on IDENIX PHARMACEUTICALS INC|
Txns:
| Granted 20,000 options to buy
@ $4.09, valued at
$81.8k
|
|